Paul Kelly 

Biography

  Paul Kelly is General Partner and Executive Director at OneVentures Pty Ltd, an Australian venture capital firm focused on investing in early stage Australian technology businesses. Dr Kelly has over 15 years of experience in commercialising life science related technologies in Australia, Europe and North America. He has co-founded a number of companies including Gemini Genomics Plc (based in UK and US, acquired by Sequenom in 2001), Agamatrix Inc. and Mears Corporation (both based in the Boston area) and was CEO of Orchid Cellmark (Nasdaq: ORCH) from 2003-2006 and more recently CEO of Medcenter Solutions, an online pharmaceutical marketing company. Dr Kelly has also served on national governmental advisory bodies, including the American Society for Medicine, Law and Ethics and presently is on the Board of Hatchtech Pty Ltd and BioSceptre International Pty Ltd. He is a graduate of the University of New South Wales where he received his Bachelor of Medicine, Bachelor of Surgery (Honours), and Doctor of Medicine degrees. He is a Fellow of the Australian College of Physicians  

Research Interest

  Physician